INTRODUCTION
============

Phosphorylation of hundreds of proteins by a small number of mitotic kinases drives correct chromosome segregation ([@B11]; [@B33]). The Aurora kinase family plays an important role in cell division and the maintenance of genomic integrity. In particular, Aurora A and B kinases control mitotic events to ensure genomic stability (reviewed in [@B40]). Aurora kinases are serine/threonine kinases that share a common substrate preference. Consequently, the substrate specificity and the function of Aurora kinases A and B are largely governed by their subcellular localization ([@B14]; [@B18]). During mitosis, Aurora A is tethered at centrosomes, where it controls bipolar spindle assembly and maintenance. In contrast, Aurora B is bound to chromosomes and then restricted to centromeres during metaphase before relocating to the spindle midzone during anaphase and midbody and the cell cortex during cytokinesis. Aurora B promotes chromosome condensation and biorientation, controls the attachment of kinetochores to microtubules, and regulates abscission during cytokinesis (reviewed in [@B40]).

Proteomic studies indicate that Aurora kinases phosphorylate a large number of substrates during mitosis ([@B21]; [@B36]). Yet the direct identification of Aurora kinase substrates and their subsequent functional analysis remains difficult. Typically Aurora kinases phosphorylate serines and threonines that fit the consensus site \[KR\]-\[KR\]-\[S/Tp\]-\[Φ\], although the substrate selectivity at P+1 is weaker ([@B4]; [@B21]) ([Figure 1A](#F1){ref-type="fig"}). Phosphorylation often occurs in unstructured regions of a protein, disrupting the region electrostatically and creating or abolishing binding sites. Some of the known substrates are Kif2c/MCAK (mitotic centromere-associated kinesin), components of the KMN network ([K]{.ul}nl1, [M]{.ul}is12 complex, [N]{.ul}dc80 complex) (Ndc80, Dsn1, and Knl1), other kinetochore components (CENP-C, CENP-E, INCENP), and centrosomal proteins such as Tpx2 ([@B1]; [@B9]; [@B32]; [@B22]; [@B39]).

![Bionformatics and validation of candidate substrates by in vitro phosphorylation assays. (A) Consensus phosphorylation motif and sequence bias in validating putative phosphorylation sites of Aurora kinases. Motif logo was generated using <http://meme-suite.org> ([@B43]) by submitting 13-amino-acid-long sequences of known Aurora kinase phosphorylation sites. (B) Schematic diagram of bioinformatic design with nonlinear flow of available filters. (C) Example of list of candidates derived from bioinformatics based on the presence of at least three consensus patterns within a 100-amino-acid region of a protein and based on biological process or localization (GO term). Numbers in brackets show predicted phosphorylation sites. (D) Coomassie-stained gels and corresponding autoradiogram showing the protein levels and levels of phosphorylation for the Ndc80 bonsai complex, ELYS~1858-2014~ (UniProt ID Q8WYP5), CLASP2~741-818~ isoform X15 (NCBI XP_006713112.1), SPICE1~549-855~ (Q8N0Z3), TTLL4~330-624~ (Q14679), and KIAA1468~1-292~ Cra_a isoform (Q96ES0), respectively. Short constructs of candidate substrates containing predicted phosphorylation were mixed with Ipl1 (yeast Aurora B kinase), buffer only, or Aurora A kinase in the presence of ^32^P-ATP. (E) Schematic diagram of SPICE1 showing the position of the coiled-coil domains (cc, red) and the predicted phosphorylation sites (red disks). (F) Coomassie-stained gel and corresponding autoradiogram showing SPICE1 (fragment 549--855), SPICE1~5A~, and SPICE1~7A~ in the presence of Ipl1 and ^32^P-ATP.](mbc-30-312-g001){#F1}

To predict novel physiological substrates of Aurora kinases, we generated a computational tool to identify Aurora kinase substrates based on the consensus sequence for the Aurora kinase (further described under *Materials and Methods*). This search tool allows filtering of potential substrates using various parameters such as the number of these consensus sites clustered within a region, presence and category in the Gene Ontology database, level of conservation across species, and level of disorder in the region containing the patterns. These parameters are controlled by the user interface and offers great search flexibility. We validated a number of predicted substrates in vitro using kinase phosphorylation assays. We also confirmed the spindle and centriole associated protein 1, residues 549--855 (SPICE1), as a novel substrate of Aurora kinases in cells. Overall, this computational tool enables a rapid search of the proteome to identify novel Aurora substrates and will be an excellent resource for the research community.

RESULTS AND DISCUSSION
======================

To search for novel Aurora kinase substrates, we established a species filter so that a potential substrate can be selected depending on Aurora kinase sites present in only up to three metazoan species (humans, zebrafish, and chickens) ([Figure 1, A and B](#F1){ref-type="fig"}). We also enabled our bioinformatics tool to select data on the basis of predicted structural disorder, number of Aurora consensus sites clustered with a small region, tissue specificity, and gene ontology (GO) terms. We designed an interface that allows the search and classification of potential substrates across species based on any combination of these parameters ([Figure 1, B and C](#F1){ref-type="fig"}).

We tested our approach by identifying known substrates in our search. We applied a species filter so that a potential substrate was only selected if at least three Aurora kinase sites were present in three metazoan species (humans, zebrafish, and chickens). Ndc80 and Kif2c (also known as MCAK) are known to be phosphorylated by Aurora A and B on multiple sites ([@B1]; [@B5]; [@B9]). Searching for substrates that contained at least three consensus sites clustered within a 100-amino-acid stretch, we found Ndc80 contains 11 Aurora consensus sites, including multiple sites in its N terminus previously identified ([@B5]; [@B9]). Human Kif2c/MCAK is predicted to have seven Aurora consensus sites, four of which have been previously identified as Aurora B kinase sites and two as Aurora A kinase sites ([@B1]; [@B47]). Searching for substrates that contained at least three Aurora consensus sites clustered within a 100-amino-acid stretch, we found 85 and 55 candidates with GO terms mitotic cell cycle and microtubules, respectively. The top candidates are listed in [Figure 1C](#F1){ref-type="fig"}. A number of these proteins have been previously identified as Aurora substrates, validating our approach. We then focused on candidates that were known to localize close to Aurora A and Aurora B kinases in mitosis but had not so far been identified as Aurora substrates.

To test whether our bioinformatics tool enabled reliable identification of novel Aurora substrates, we selected five mitotic candidates that were predicted as Aurora substrates containing clusters of phosphorylation sites (at least three phosphorylation sites within 100 amino acids) but not previously reported as Aurora kinase substrates. We purified these recombinantly expressed proteins and used in vitro kinase assays to test whether they were phosphorylated by Aurora A and the yeast Aurora B kinase Ipl1. As a positive control, we used the Ndc80 bonsai complex, which is phosphorylated in the N terminus by Aurora kinases ([@B5]; [@B9]; [@B6]; [@B41]). Ndc80 was phosphorylated by both Aurora A and Ipl1 ([Figure 1D](#F1){ref-type="fig"}). Then we tested the nucleoporin Elys and microtubule binding protein Clasp2, which both localize to kinetochores in mitosis. Elys and Clasp2 were predicted to have 26 and 19 phosphorylation sites in total. We recombinantly expressed and purified domains of Elys (residues 1818--2014) and Clasp2 (residues 741--818), containing multiple predicted phosphorylation sites (4 and 5, respectively). Both appeared strongly phosphorylated by Aurora kinases ([Figure 1D](#F1){ref-type="fig"}). Interestingly, the Clasp2 domain is in the microtubule-binding glutamate-arginine--rich region, containing two EB-binding SXIP motifs and heavily regulated by glycogen synthase kinase 3 (GSK3) phosphorylation ([@B24]). Aurora kinases A and B also phosphorylate tubulin tyrosine ligaselike polyglutamylase residues 330--624 (TTLL4), which regulates microtubule posttranslational modifications ([Figure 1D](#F1){ref-type="fig"}). We found that Aurora kinases A and B also phosphorylate the C terminus of SPICE1 ([Figure 1, D and E](#F1){ref-type="fig"}). Finally, the role of KIAA1468 is not known; however, we found this protein had sequence similarities to the microtubule-binding protein tumor overexpressed gene (TOG), comprising a number of TOG-like domains. We found that the N terminus of KIAA1468 (residues 1--292) was phosphorylated by both Ipl1 and Aurora A kinase.

We focused further on SPICE1 as an Aurora substrate and generated a nonphosphorylatable SPICE1~5A~, with the predicted phosphorylated residues mutated to alanines (residues T557, S738, T780, S797, and S810; [Figure 1E](#F1){ref-type="fig"}). T557 has also previously been found phosphorylated in vivo ([@B30]; [@B20]). Additionally, two sites neighboring the predicted phosphorylation sites: T798 and S811 also match the Aurora consensus closely and have been reported to be phosphorylated in mass spectrometry studies ([@B11]; [@B30]; [@B20]). Aurora kinases are capable of phosphorylating consecutive target residues such as the TSS motif in INCENP ([@B3]; [@B19]). Thus these sites were included to make a SPICE1~7A~ construct ([Figure 1E](#F1){ref-type="fig"}). Phosphorylation of SPICE1~5A~ by the yeast Aurora B kinase Ipl1 was strongly reduced, while phosphorylation of SPICE1~7A~ was almost abolished, indicating that the seven sites were Aurora kinase phosphorylation sites in vitro ([Figure 1F](#F1){ref-type="fig"}). In total, our bioinformatics approach predicts Aurora kinase substrates in vitro accurately and enables the discovery of new mitotic substrates of Aurora kinases.

We then investigated whether these substrates were regulated by Aurora kinases in vivo and focused on SPICE1. Since the C terminus of SPICE1 is phosphorylated in vitro by Aurora kinases ([Figure 1F](#F1){ref-type="fig"}), we examined the role of the C terminus of SPICE1 on its cellular localization in mitosis. Full-length SPICE1 targets to the spindle and centrioles, in agreement with previous work, while SPICE1~444-855~ failed to localize ([Figure 2A](#F2){ref-type="fig"}) ([@B2]). SPICE1~1-550~ localized to the spindle and centrioles ([Figure 2A](#F2){ref-type="fig"}) ([@B2]), however its spindle localization was weakened when compared with full-length SPICE1 ([Figure 2, B and C](#F2){ref-type="fig"}). This indicates that the C terminus of SPICE1 enhances its targeting to the spindle, despite not targeting to microtubules directly ([Figure 2](#F2){ref-type="fig"}). SPICE1~1-550~ failed to cause centriole amplification whilst the overexpression of full-length SPICE1 caused supernumerary centrioles ([Figure 2, C and D](#F2){ref-type="fig"}), indicating that the C terminus of SPICE1 contributes positively to control of centriole number.

![The C terminus of SPICE1 regulates SPICE1 targeting to microtubules and centriole number in cells. (A) Representative live-cell images of HeLa cells transfected with GFP-SPICE1, GFP-SPICE1~1-550~, and GFP-SPICE1~444-855~ in mitosis and interphase. (B) Quantification of GFP signal intensity on microtubules. Each data point represents one cell for which a background-corrected mean integrated intensity of the GFP signal on MTs was normalized to GFP-SPICE1 fluorescence intensity (GFP-SPICE1 *n* = 21; GFP-SPICE1~1-550~, *n* = 34). The error bars represent the SEM. The *p* value for Student's *t* test is \*\*\*\*\<0.0001. (C) Representative deconvolved maximum z-projections of the HeLa cells transiently expressing GFP-SPICE1 or GFP-SPICE1~1-550~, immunostained with anti--β-tubulin and anti-centrin antibodies, and stained with Hoechst for DNA. (D) Quantification of centriole number based on centrin staining in HeLa cells transiently expressing GFP-SPICE1 or GFP-SPICE1~1-550~ (control *n* = 31; GFP-SPICE1 *n* = 30; GFP-SPICE1~1-550~ *n* = 34). The error bars represent the SD. The *p* values for Kolmogorov--Smirnov test are \*\*\*\*\<0.0001. Scale bars, 5 μm.](mbc-30-312-g002){#F2}

We established functional assays to test how Aurora kinases may regulate SPICE1 function through C-terminal phosphorylation. We first generated an inducible SPICE1 knockout cell line using CRISPR/Cas9-mediated gene targeting ([@B27]). After 96 h of Cas9 induction, we examined the levels of SPICE1 depletion (Supplemental Figure S1, A and B). SPICE1 depletion was largely successful (Supplemental Figure S1B). In control cells, 82% of untreated cells had a total of four centrioles, as marked by centrin foci staining (Supplemental Figure S1C). The number of centrioles was increasingly abnormal in doxycycline-treated SPICE1-knockout cells with 48% cells having more or less than four centrin foci (Supplemental Figure S1C). Chromosomes showed increased misalignment, 51% misaligned in SPICE1-knockout cells, while only 25% of untreated cells displayed misaligned chromosomes (Supplemental Figure S1D). There were also spindle organization defects and multipolarity in 31% of SPICE1-knockout cells, while only 7% of untreated cells displayed multipolar spindles (Supplemental Figure S1E).

We then used silencing RNA (siRNA) to deplete SPICE1 and confirm the knockout phenotype observed for SPICE1 (Supplemental Figure S1, F and G). While 90% of control cells displayed four centrioles, only 65% of SPICE1 RNA interference (RNAi)-depleted cells had four centrioles (Supplemental Figure S1H) and 27% of cells had fewer than four centrioles. Respectively, 8 and 48% of control and SPICE1-RNAi-depleted cells displayed misaligned chromosomes (Supplemental Figure S1I). We found that on successful depletion of SPICE1, there was an increase in frequency of multipolar spindles, with 21% of cells displaying a multipolar spindle phenotype (Supplemental Figure S1J). Overall, the phenotype of SPICE1 knockout was similar to the published RNAi-based SPICE1 knockdown and our SPICE1 siRNA depletion ([@B2]).

Since SPICE1 is phosphorylated in vitro by Aurora kinases, we wanted to test whether SPICE1 localization is regulated by Aurora kinases in cells. Thus we examined the localization of SPICE1 on Aurora kinase inhibition using small molecule Aurora B- and Aurora A-specific inhibitors ZM447439 and MLN8237, respectively ([@B8]). Histone H3 is an established Aurora B kinase substrate. First, we confirmed that ZM447439 treatment was successful in inhibiting Aurora kinase B at a concentration where it has minimal activity on Aurora A, as Histone H3 was no longer phosphorylated after ZM447439 treatment ([@B8]; [@B10]). Histone H3 phosphorylation persisted after MLN8237 treatment (Supplemental Figure S2A), indicating that MLN8237 inhibited specifically Aurora A kinase as previously showed ([@B41]). In the absence of Aurora kinase inhibition, green fluorescent protein (GFP)-SPICE1 localizes to the centrioles and the spindle. After a 1.5 h treatment with ZM447439 and MLN8237, GFP-SPICE1 targeting to the spindle was strongly reduced ([Figure 3, A and B](#F3){ref-type="fig"}). However, SPICE1 could still localize to centrioles. Similarly, the spindle localization of endogenous SPICE1 was also strongly reduced in the absence of Aurora kinase activity but not its centriole localization ([Figure 3, C and D](#F3){ref-type="fig"}). Next we wanted to test whether the nonphosphorylatable SPICE1~SA~ and phosphomimetic SPICE~SE~ mutants displayed any changes in localization with respect to SPICE1. GFP-SPICE1~5A~ and GFP-SPICE1~7A~ were strongly reduced on the spindle as expected, whereas GFP-SPICE1~5E~ and GFP-SPICE1~7E~ remained present on the spindle with levels similar to GFP-SPICE1 ([Figure 4, A and B](#F4){ref-type="fig"}). In total, these results indicate that Aurora kinase phosphorylation contributes to regulating the targeting of SPICE1 to the spindle.

![Aurora kinases regulate the cellular localization of SPICE1 to microtubules. (A) Representative deconvolved maximum z-projections of SPICE1-depleted HeLa cells and transiently transfected with GFP-SPICE1 after treatment with dimethyl sulfoxide (DMSO) (control), Aurora A inhibitor MLN8237, or Aurora B inhibitor ZM447439. Cells were immunostained with anti--β-tubulin and anti-centrin antibodies and stained with Hoechst for DNA. (B) Scatter plot showing the average normalized GFP fluorescence intensity on microtubules relative to the GFP fluorescence on microtubules in DMSO-treated metaphase cells. Each data point represents background-corrected integrated intensity of the GFP signal on microtubules (DMSO *n* = 40; MLN8237 *n* = 38; ZM447439 *n* = 30). (C) Representative deconvolved maximum z-projections of HeLa cells treated with DMSO, MLN8237, or ZM447439 and immunostained with anti-SPICE1 and anti--β-tubulin antibodies. (D) Scatter plot showing normalized SPICE1 fluorescence intensity on microtubules relative to the fluorescence intensity of SPICE1 on microtubules in DMSO-treated metaphase cells. Experiment repeated twice (DMSO *n* = 42; MLN8237 *n* = 38; ZM447439 *n* = 27). The error bars represent the SEM. The *p* values for one-way ANOVA tests are reported: \*\*\*\**p* \< 0.0001. Scale bars, 5 μm.](mbc-30-312-g003){#F3}

![Constitutive phosphorylation of SPICE1 results in abnormal centriole number, chromosome alignment defects and spindle multipolarity. (A) Representative deconvolved immunofluorescent images showing the maximum projections of SPICE1-depleted HeLa cells transfected with GFP-SPICE1 mutants and costained with anti--β-tubulin and anti-centrin antibodies. (B) Scatter plot showing the average normalized GFP fluorescence intensity of SPICE1 mutants on microtubules relative to the fluorescence of GFP-SPICE1 on microtubules. The error bars represent the SEM. Experiment repeated twice (HeLa, WT *n* = 55; 5A *n* = 57; 7A *n* = 66; 5E *n* = 46; 7E *n* = 58). The *p* values for the one-way ANOVA test are reported: \*\*\*\**p* \< 0.0001. Scale bars, 5 μm. (C--E) Graphs showing quantifications of the percentage of cells with centriole defects, chromosome alignment defects, and spindle defects in HeLa cells depleted of endogenous SPICE1 while transiently expressing GFP-SPICE1 or GFP-tagged phosphorylation mutants. Measured in two experiments (control RNAi *n* = 78; SPICE RNAi *n* = 77; SPICE RNAi + SPICE1 WT *n* = 63; SPICE RNAi + SPICE1~5A~ *n* = 60; SPICE RNAi + SPICE1~7A~ *n* = 66; SPICE RNAi + SPICE1~5E~ *n* = 46; SPICE RNAi + SPICE1~7E~ *n* = 59).](mbc-30-312-g004){#F4}

SPICE1 is a centriole- and spindle-associated protein implicated in regulating centriole number and length, as well as a role in spindle organization ([@B2]; [@B7]). However, the molecular mechanism underpinning its function is not known. To test whether constitutive phosphorylation could affect SPICE1 function, we examined the spindle morphology, centriole number, and chromosome alignment in the presence of the SPICE1 mutants and in the absence of endogenous SPICE1. First, we established that siRNA-resistant GFP-SPICE1 could rescue chromosome misalignment defects, multipolar spindles, and centriole number defects ([Figure 4](#F4){ref-type="fig"} and Supplemental Figure S1F). Of control cells, 96% had bipolar spindles. Similarly, 94, 97, and 100% of cells expressing GFP-SPICE1, GFP-SPICE1~5A~, and GFP-SPICE1~7A~ displayed bipolar mitotic spindles ([Figure 4C](#F4){ref-type="fig"}). In the absence of endogenous SPICE1, rates of chromosome alignment in GFP-SPICE1~5A~ and GFP-SPICE1~7A~ transfected cells were similar to control cells and siRNA-resistant GFP-SPICE1--rescued cells ([Figure 4, A and D](#F4){ref-type="fig"}). The number of centrin foci observed for control cells was also similar to that of GFP-SPICE1, GFP-SPICE1~5A~, and GFP-SPICE1~7A~, with 90% control cells having four centrioles and 86, 83, and 88% for GFP-SPICE1, GFP-SPICE1~5A~, and GFP-SPICE1~7A~, respectively ([Figure 4, A and E](#F4){ref-type="fig"}). In contrast, GFP-SPICE1~5E~ and GFP-SPICE1~7E~ transfected cells displayed an increase in chromosome alignment defects and in multipolar spindles, similarly to SPICE1-depleted cells. GFP-SPICE1~5E~ and GFP-SPICE1~7E~ transfected cells displayed more multipolar spindles, 15 and 17% of cells, respectively, while 21% of SPICE1-depleted cells had multipolar spindles ([Figure 4, A and C](#F4){ref-type="fig"}). There was an accumulation of mitotic cells, and less than 50% of the cells displayed aligned chromosomes in both GFP-SPICE1~5E~-- and GFP-SPICE1~7E~--transfected cells, reminiscent of SPICE1-depleted cells ([Figure 4, A and D](#F4){ref-type="fig"}). GFP-SPICE1~5E~-- and GFP-SPICE1~7E~--expressing cells also displayed an increase in the abnormal centriole number similarly to SPICE1-depleted cells, as marked by the number of centrin foci ([Figure 4E](#F4){ref-type="fig"}). Only 70 and 52% of GFP-SPICE1~5E~-- and GFP-SPICE1~7E~--expressing cells had four centrioles, respectively ([Figure 4, A and E](#F4){ref-type="fig"}). Overall, the phenotypes observed in GFP-SPICE1~5E~-- and GFP-SPICE1~7E~--expressing cells were very similar to that of SPICE1-depleted cells. Aurora phosphorylation of SPICE1 plays a role in down-regulating the activity of SPICE1. In total, our results indicate that the dynamic phosphorylation of SPICE1 is essential for correct centriole number, spindle architecture, and chromosome segregation.

Large proteomic approaches and peptides array studies have identified many mitotic substrates ([@B11]; Dulla *et al.*, 2010; [@B29]). However, the kinase responsible for the phosphorylation is not necessarily associated with these sites. Additionally, phosphopeptides are often missed, as they are less easily ionized than other peptides. To identify new Aurora kinase substrates, we have used a computational approach and developed a searchable database for Aurora kinase phosphorylation consensus sites, with criteria that the user can select ([Figure 1B](#F1){ref-type="fig"}). Selection factors include both the number of sites and phosphorylation site clustering: many Aurora kinase phosphorylation sites are found in close proximity to each other as demonstrated for Kif2c/MCAK and the KMN network ([@B1]; [@B39]; [@B42]). Many functionally important phosphorylation sites are conserved across species and are located in disordered regions, and both features can be used here as search parameters. Finally, Gene Ontology is also used to classify the candidate proteins based on their function and localization, focusing on cell division and the cell cycle due to the mitotic role of Aurora kinases. Applying these criteria to mitotic and spindle associated proteins, we could correctly predict a number of known Aurora kinase substrates such as Ndc80, Numa1, Tpx2, Dsn1, and Kif2c/MCAK ([Figure 1C](#F1){ref-type="fig"}) ([@B1]; [@B5]; [@B9]; [@B15]; [@B16]). From the other candidates identified in our study, we tested whether the nucleopore- and kinetochore-localized Elys, plus-end associated Clasp2, spindle- and centriole-associated SPICE1, tubulin polyglutamylase TTLL4, and an unknown protein KIAA1468 were Aurora kinase substrates. All were successfully phosphorylated by Aurora A and Aurora B in vitro, showing that our computational approach to predict Aurora kinase phosphorylation sites is relevant and accurate. Very recently, Elys has been reported to have a protein phosphatase 1 (PP1)-binding motif (RV\[S/Tp\]F), phosphorylated by Aurora B, confirming our finding that Elys is an Aurora kinase substrate ([@B31]). Clasp2 is present at centrosomes, kinetochores, and microtubule plus ends, making it a prime candidate for Aurora kinase phosphorylation. Additionally, many of the predicted phosphorylation sites are localized in the glutamate-arginine--rich region phosphorylated by GSK3 ([@B23]). This region appears to regulate Clasp2 targeting to microtubules through disruption of two SXIP motifs and possibly through other mechanisms ([@B23]; [@B34]). Thus Aurora B phosphorylation of this region could provide a mitotic control of microtubule targeting. Many other Aurora substrates predicted in our database remain to be identified as such in vivo.

SPICE1 is implicated in centriole duplication and elongation, spindle integrity, and chromosome alignment ([@B2]; [@B7]). While the SPICE1 N terminus contains the microtubule-binding region based on cellular localization ([@B2]) ([Figure 2A](#F2){ref-type="fig"}), the C terminus appears as the regulatory region of the protein. Our results indicate that full-length SPICE1 overexpression results in abnormal centriole numbers with an increase in supernumerary centrioles ([Figure 2, C and D](#F2){ref-type="fig"}). In the absence of the SPICE1 C terminus, cells overexpressing SPICE1 did not display any extra centrioles ([Figure 2, C and D](#F2){ref-type="fig"}). Our analysis of SPICE1 regulation by Aurora kinases revealed that the C terminus of SPICE1 contains seven Aurora kinase phosphorylation sites. Mutants carrying the computationally predicted phosphorylation sites to alanines did not cause any cellular defects. Spindle architecture and centriole number was similar to that in control cells. SPICE1 nonphosphorylatable mutants did not localize to the spindle but remain present at centrioles, suggesting that SPICE1 centriole localization rather than spindle localization is important for maintaining centriole number. SPICE1 also promotes centriole elongation. However, it was not possible for us to measure centriole length in the presence of SPICE1 mutants, due to a lack of resolution of centrioles by conventional fluorescence microscopy.

The SPICE1 phosphomimetic mutant localized both to centrioles and spindles. Cells expressing a constitutive SPICE1 phosphomimetic mutant display spindle architecture defects, modest chromosome misalignment, and abnormal centriole number, reminiscent of SPICE1 depletion. Thus constitutive phosphorylation appears to interfere with SPICE1 function, possibly by allowing the N-terminal microtubule-binding region to associate with microtubules, in a noncontrolled manner. While the phosphorylation status of SPICE1 does not seem to regulate its centriole localization, centriole-localized SPICE1 may recruit proteins important to regulate centriole replication in an Aurora kinase-dependent manner. Consequently, the presence of phosphomimetic SPICE1 results in abnormal centriole regulation. Both an increase and a reduction in centriole number interfere with force balance in the spindle and can result in multipolarity ([@B28]). Multipolarity in turn can cause chromosome misalignment ([@B17]). Thus we believe that the SPICE1-induced centriole misregulation can cause the observed phenotype. Phosphorylation of SPICE1 promotes its association with the spindle ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). This could also interefere with microtubule dynamics, leading to spindle defects and chromosome misalignment. We conclude that dynamic phosphorylation of SPICE1 by Aurora kinases is necessary to maintain correct spindle architecture and centriole number. Aurora kinases are tethered to the centrosomes, chromosomes, and kinetochores. Cytoplasmic counteracting phosphatases are likely to dephosphorylate SPICE1 in a manner inversely proportional to its distance from the Aurora kinases to reduce the levels of SPICE1 on the spindle. We could not observe a localization gradient of SPICE1 after Aurora kinase inhibition. This could be due to the length of the inhibitor treatment, or the fixing conditions, which do not preserve the localization of weakly bound proteins to microtubules ([@B38]). Recently, in addition to its centrosome localization, Aurora A has been reported at kinetochores, which could explain the absence of SPICE1 localization gradient ([@B10]; [@B44]). Further, molecular studies on SPICE1 are necessary to dissect the mechanism of SPICE1 in centriole and spindle function.

Overall, our computational approach reveals a rapid way to identify new Aurora kinase substrates and represents a user-friendly open-source tool for the community. Using this approach, we have identified multiple new Aurora kinase substrates in vitro and showed that SPICE1 is an Aurora kinase substrate both in vitro and in vivo, validating our approach.

MATERIALS AND METHODS
=====================

Cloning, protein expression, and purification
---------------------------------------------

Genes of interest were PCR amplified from adult male testis or fetus brain cDNA library (Invitrogen) and inserted into pET3aTr and pBabe GFP blasticidin for bacterial expression and for transfections into human cells, respectively. Site-directed mutagenesis was performed using QuikChange (Agilent Technologies). Sequences were verified. A list of constructs and primers is provided in [Table 1](#T1){ref-type="table"}.

###### 

Details of constructs generated and primer sequences.

  Amplification from cDNA library   Primer sequence                    
  --------------------------------- ---------------------------- -- -- --
  Full-length ELYS                  GTGGAACTCGGTTTTGTCGG               
                                    CCTGGACTGAAACAATCACTCC             
  Full-length TTLL4                 CAGACTGACAGACTTCAAGGATGC           
                                    AGGCTTTTGGAGAGAGGCCAG              
  Full-length SPICE1                CTGTGTTTTGAGAGTGCAAGTACG           
                                    GAACAAACTCAGTGAGACTTGACTTC         

  Bacterial expression                              Primer sequence                                                                                             Vector    Enzymes/method            Template
  ------------------------------------------------- ----------------------------------------------------------------------------------------------------------- --------- ------------------------- -----------------------------------
  ELYS~1858-2014~-3C protease cleavage site-6xHis   gaaggagatata[catatg]{.ul}ACTAAAAAAGAAGTTAAGGTTTCATC                                                         pET3aTr   *Nde*l/Gibson assembly    ELYS isoform 2 NP_001310271.1
                                                    ccaagcttagatct[ggatcc]{.ul}TCAGTGGTGATGATGATGATGGCTGCTGCCGGGCCCCTGGAACAGAACTTCCAGTGGGGTATTTCTTGTAGATCTCC    pET3aTr   *Bam*HI/Gibson assembly   ELYS isoform 2 NP_001310271.1
  CLASP2~741-818~-3C protease cleavage site-6xHis   gaaggagatata[catatg]{.ul}CCATCTAGGCTTTCAGTGGC                                                               pET3aTr   *Nde*I/Gibson assembly    CLASP2 isoform X15 XP_006713112.1
                                                    ccaagcttagatct[ggatcc]{.ul}TCAGTGGTGATGATGATGATGGCTGCTGCCGGGCCCCTGGAACAGAACTTCCAGAGAAGACGACAGTCGACTTGATTG   pET3aTr   *Bam*HI/Gibson assembly   CLASP2 isoform X15 XP_006713112.1
  SPICE1~549-855~-3C protease cleavage site-6xHis   tttaagaaggagatata[catatg]{.ul}CCTCTTCAGGACGTATTGAG                                                          pET3aTr   *Nde*I/Gibson assembly    SPICE1 isoform a NP_001318007.1
                                                    ccaagcttagatct[ggatcc]{.ul}TCAGTGGTGATGATGATGATGGCTGCTGCCGGGCCCCTGGAACAGAACTTCCAGTGATACATGGGTAGAAAGAGCA     pET3aTr   *Bam*HI/Gibson assembly   SPICE1 isoform a NP_001318007.1
  TTLL4~330-624~-3C protease cleavage site-6xHis    tttaagaaggagatata[catatg]{.ul}CCAACTAAGGAGATTCGGTTC                                                         pET3aTr   *Nde*I/Gibson assembly    TTLL4 NP_055455.3
                                                    ccaagcttagatct[ggatcc]{.ul}TCAGTGGTGATGATGATGATGGCTGCTGCCGGGCCCCTGGAACAGAACTTCCAGTCCAATGGTCTGCTTGACAATG     pET3aTr   *Bam*HI/Gibson assembly   TTLL4 NP_055455.3
  KIAA1468~1-292~-3C protease cleavage site-6xHis   tttaagaaggagatata[catatg]{.ul}TTAGTACAGAAATTAGAAGATAAAATTAGTTTG                                             pET3aTr   *Nde*I/Gibson assembly    KIAA1468 isoform CRA_a EAW63120.1
                                                    ccaagcttagatct[ggatcc]{.ul}TCAGTGGTGATGATGATGATGGCTGCTGCCGGGCCCCTGGAACAGAACTTCCAGTAACATTTGTTGCAACATTGAAAG   pET3aTr   *Bam*HI/Gibson assembly   KIAA1468 isoform CRA_a EAW63120.1

  Mammalian expression     Primer sequence                                 Vector        Enzymes/method   Template
  ------------------------ ----------------------------------------------- ------------- ---------------- --------------------------
  Full-length GFP-SPICE1   cccg[CTCGAG]{.ul}ATGTCATTTGTCAGAGTGAACCGCT      pBabe blast   *Xho*I           Isoform a NP_001318007.1
                           tccc[CCGCGG]{.ul}TTATGATACATGGGTAGAAAGAGCAAAC   pBabe blast   *Sac*II          Isoform a NP_001318007.1
  GFP-SPICE1~444-855~      ccc[CTCGAG]{.ul}ATATCACTCACACATGCTATTAAGAACT    pBabe blast   *Xho*I           Isoform a NP_001318007.1
  GFP-SPICE1~1-550~        tccc[CCGCGG]{.ul}TTAAAGAGGAGAGAATTTTAAGT        pBabe blast   *Sac*II          Isoform a NP_001318007.1

  Mutagenesis                 Primer sequence                                                           
  --------------------------- ------------------------------------------------------------------- -- -- --
  GFP-SPICE1 hd 1st 5 bases   CTCCCAGTACTGGGAGATGGGCAGCAATTAAGGACTAATGAGTCATTAATACAAAGAAAGGAC           
                              GTCCTTTCTTTGTATTAATGACTCATTAGTCCTTAATTGCTGCCCATCTCCCAGTACTGGGAG           
  GFP-SPICE1 hd 2nd 5 bases   CTGGGAGATGGGCAGCAATTAAGGACTAACGAAAGTTTAATACAAAGAAAGGACATAATGACACG         
                              CGTGTCATTATGTCCTTTCTTTGTATTAAACTTTCGTTAGTCCTTAATTGCTGCCCATCTCCCAG         
  GFP-SPICE1 T557A            AGGACGTATTGAGAAGGGCTGTTCAAACTCGTCCT                                       
                              AGGACGAGTTTGAACAGCCCTTCTCAATACGTCCT                                       
  GFP-SPICE1 S738A            TTGCAGAATTGAATCGACAAGCTATGGAGGCTCGTGGAAAAC                                
                              GTTTTCCACGAGCCTCCATAGCTTGTCGATTCAATTCTGCAA                                
  GFP-SPICE1 T780A            GACTGAAGGAGCAAAGAGGGCAATTGAGGTATCTATTCC                                   
                              GGAATAGATACCTCAATTGCCCTCTTTGCTCCTTCAGTC                                   
  GFP-SPICE1 S797A            CCCAGAAAGCTCAAAATGTGCTACTGTCTCTCCCGTCAGC                                  
                              GCTGACGGGAGAGACAGTAGCACATTTTGAGCTTTCTGGG                                  
  GFP-SPICE1 S810A Forward    GCGGGATAAATACAAGAAGAGCTTCCGGGGCTACT                                       
                              AGTAGCCCCGGAAGCTCTTCTTGTATTTATCCCGC                                       
  GFP-SPICE1 S797A/T798A      GCCCCAGAAAGCTCAAAATGTGCTGCTGTCTCTCCCGTCAG                                 
                              CTGACGGGAGAGACAGCAGCACATTTTGAGCTTTCTGGGGC                                 
  GFP-SPICE1 S810A/S811A      TCAGCGGGATAAATACAAGAAGAGCTGCCGGGGCTACTG                                   
                              CAGTAGCCCCGGCAGCTCTTCTTGTATTTATCCCGCTGA                                   
  GFP-SPICE1 T557E            CTTCAGGACGTATTGAGAAGGGAAGTTCAAACTCGTCCTGCTCCA                             
                              TGGAGCAGGACGAGTTTGAACTTCCCTTCTCAATACGTCCTGAAG                             
  GFP-SPICE1 S738E            GGAACGGATTGCAGAATTGAATCGACAAGAAATGGAGGCTCGTGGA                            
                              TCCACGAGCCTCCATTTCTTGTCGATTCAATTCTGCAATCCGTTCC                            
  GFP-SPICE1 T780E            GGACTGAAGGAGCAAAGAGGGAAATTGAGGTATCTATTCCAG                                
                              CTGGAATAGATACCTCAATTTCCCTCTTTGCTCCTTCAGTCC                                
  GFP-SPICE1 S797E            GCAGAAGCCCCAGAAAGCTCAAAATGTGAAACTGTCTCTCCCGT                              
                              ACGGGAGAGACAGTTTCACATTTTGAGCTTTCTGGGGCTTCTGC                              
  GFP-SPICE1 S810E            CCCGTCAGCGGGATAAATACAAGAAGAGAATCCGGGGCTACTGG                              
                              CCAGTAGCCCCGGATTCTCTTCTTGTATTTATCCCGCTGACGGG                              
  GFP-SPICE1 S797E/T798E      GGAGCAGAAGCCCCAGAAAGCTCAAAATGTGAAGAAGTCTCTCCCGTCAGCGGGA                   
                              TCCCGCTGACGGGAGAGACTTCTTCACATTTTGAGCTTTCTGGGGCTTCTGCTCC                   
  GFP-SPICE1 S810E/S811E      AGAAGTCTCTCCCGTCAGCGGGATAAATACAA GAAGAGAAGAGGGGGCTACTGGTAATTCTT           
                              AAGAATTACCAGTAGCCCCCTCTTCTCTTCTTGTATTTATCCCGCTGACGGGAGAGACTTCT            

  CRISPR Cas9                                  Oligo sequence                         Vector        Enzymes/method   
  -------------------------------------------- -------------------------------------- ------------- ---------------- --
  guide RNA targeting exon3 in *SPICE1* gene   \[phospho\]caccgTTCGGGAGTTGCCCGATGAA   pLentisgRNA   *Bbs*I           
                                               \[phospho\]aaacTTCATCGGGCAACTCCCGAAc   pLentisgRNA   *Bbs*I           

Recombinant proteins were expressed in BL21 (DE3) Codon plus cells with a His-tag preceded by 3C protease cleavage site. Protein expression and purification was performed as described ([@B37]). To isolate the KIAA1468~1-292~ fragment from the inclusion bodies and refold it, 100 ml of the cells expressing KIAA1468~1-292~ was centrifuged, and cell pellets were resuspended in lysis buffer (50 mM Tris--HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 10 mM dithiothreitol \[DTT\]). After repeated freeze--thaw cycles, the cell lysate was sonicated, and insoluble fraction was collected by centrifugation for 20 min at 15,000 rpm and 4°C. Inclusion bodies in pellet were washed three times with wash buffer (50 mM Tris--HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM DTT), sonicated briefly, and pelleted at 15,000 rpm for 20 min at 4°C. Inclusion bodies were solubilized into 6 M Gdn--HCl, pH 4.5, and 5 mM b-mercaptoethanol (BME) stirring at room temperature. After solubilization, the buffer was exchanged with wash buffer (50 mM Tris--HCl, pH 8.0, 100 mM NaCl, 6 M urea, 10 mM imidazole, 5 mM BME) using desalting column (BioRad). The sample was then dialyzed against refolding buffer (50 mM Tris--HCl, pH 8.0, 100 mM NaCl, 4 M urea, 1 mM EDTA, 10% glycerol, 0.5 mM [l]{.smallcaps}-arginine) for 4 h at 4°C. The stepwise refolding continued with dialysis against the buffers with decreasing concentration of urea and finished with buffer without urea. The protein refolded properly without aggregation.

In vitro kinase assay and Western blotting
------------------------------------------

Purified recombinant protein fragments (2 μg) were incubated with 1.1 μg purified yeast recombinant glutathione-*S*-transferase--Ipl1, 0.2 μg human recombinant His-Aurora A (AMS Biotechnology Ltd.), or water in kinase buffer (150 mM NaCl, 40 mM HEPES, pH 7, 5 mM MgCl, 2 mM DTT, 20% glycerol) for 30 min at 37°C in the presence of 10 mM ATP and 5 μCi \[γ-^32^P\] ATP. The kinase reaction mixtures were resuspended in SDS sample buffer and separated with 10% or 15% SDS--PAGE. To detect phosphorylation, dried gels were exposed to an x-ray film (Fuji-Film). Simultaneously, same samples were prepared without \[γ-^32^P\] ATP and run out with SDS--PAGE, and gels were stained with Coomassie Brilliant Blue. For Western blotting, HeLa cells were lysed in SDS sample buffer and equal amount of cell extract per lane were loaded into a SDS--PAGE gel, run out, transferred to a nitrocellulose membrane, and blotted with rabbit anti-SPICE1 (HPA064843; Atlas Antibodies) and mouse anti--β-tubulin (Sigma) as loading control.

Cell culture and microscopy
---------------------------

Cells were maintained in DMEM (Lonza) supplemented with 10% fetal bovine serum penicillin/streptomycin (Life Technologies) at 37°C in a humidified atmosphere with 5% CO~2~. Cells were checked monthly for mycoplasma contamination (Mycoalert kit; Lonza). Cells were plated on 18-mm glass coverslips coated with poly-[l]{.smallcaps}-lysine (Sigma-Aldrich) for immunostaining. Transient transfections of DNA were conducted using Effectene reagent (Qiagen) according to the manufacturer's guidelines. RNAi experiments were conducted using jetPRIME transfection reagent (Polyplus) according to the manufacturer's protocol. Previously published siRNA oligo was used to deplete SPICE1 ([@B2]). The cells were visualized 48 h after transfection or cotransfection.

The inducible SPICE1 knockout (KO) cell line was generated as previously described ([@B45]; [@B46]) using guide RNA (gRNA) 5′-TTCGGGAGTTGCCCGATGAA-3′, targeting exon 3 of *SPICE1*. KO was introduced with 1 μg/ml doxycycline (Sigma) treatment of stable HeLa Cas9~SPICE1\ gRNA~ cells for 96 h. For Aurora kinase inhibition experiments, HeLa cells were incubated for 1.5 h with small molecule inhibitors at the following concentrations: ZM447439, 2 µM; MLN8237, 150 nM (Selleckchem).

Immunofluorescence in human cells was conducted as previously described ([@B39]) using antibodies against mouse anti-tubulin (Sigma), rabbit anti-Centrin (Covance; custom-made), and rabbit α-SPICE1 (HPA064843; Atlas Antibodies). Images were acquired on a DeltaVision Core deconvolution microscope (Applied Precision) equipped with a CoolSnap HQ2 CCD camera. Thirty Z-sections were acquired at 0.2-nm steps using a 100×/1.3 NA Olympus U-PlanApo objective without binning. Equivalent exposure conditions were used between controls and drug-treated cells in a single experiment, as well as in case of nontransfected cells and cells transfected with different constructs. On average, experiments were repeated three times. To quantitate GFP fluorescence intensity, at least 10 individual MT as polylines of 35--37 pixels in size were selected from projections (selected based on colocalization with β-tubulin) and the integrated intensity was determined after subtracting the average background fluorescence measured from adjacent regions of the cell (two polylines form inside and two from outside the spindle) using Metamorph. To quantify chromosome congression defects in SPICE1 knockdown and KO, the cells were scored as having congressed chromosome, mild congression defects, and severe congression defects based on Hoechst staining. The cells with at least five misaligned chromosomes were scored as mild congression defects; the cells with more than five misaligned chromosomes as cells with severe defects. To quantify spindle morphology defects, the cells were scored as having bipolar or multipolar spindle based on β-tubulin staining and spindle morphology. To quantify defects in centriole numbers, the cells were scored as having \<4, 4, and \>4 centrioles based on centrin staining. Integrated intensities of pS10-H3 signals were measured from chromatin surface (based on Hoechst staining) using Image-Pro-Premier software (Media Cybernetics).

Images were stored and vizualised using an OMERO.insight client ([@B26]).

Statistics and reproducibility
------------------------------

Statistical analyses were performed using GraphPad Prism 6.0 or R software. No statistical method was used to predetermine sample size. No samples were excluded from the analyses. All experiments were performed and quantified from at least three independent experiments, unless specified, and the representative data are shown.

Statistical analysis of data was performed with GraphPad Prims using Student's *t* test, one-way analysis of variance (ANOVA) tests, and nonparametric tests. A Kolmogorov--Smirnov test was used to test variation in centriole number ([Figure 2D](#F2){ref-type="fig"}), which had a non-Gaussian distribution.

Data availability
-----------------

All data supporting the findings of this study are available from the corresponding author on request.

Software
--------

*fuzzpro* from the EMBOSS suite (version 6.6.0.0) was used to find matches to patterns in each of the three peptide data sets ([@B35]). Needle from the same suite was used to calculate the percentage identity between all possible pairwise regions that contained pattern matches in orthologous proteins, and the highest identity per pair was recorded. *iupred* ([@B12]) was used to calculate the likelihood for an amino acid regions present in a disordered region. Amino acids that have values larger than 0.5 were counted within regions containing a pattern match. *samtools* (version 0.1.19) was used to both index and retrieve sequences from the fasta files ([@B25]).

Shiny application
-----------------

The R-Shiny application can be launched in any R session with an installed shiny package using the commands

library (shiny)

runGitHub ("DereticWelburnApp," "AlastairKerr")

The interface produces a table for proteins that match at least one of the prosite patterns in each of the three orthologues.

Prosite patterns used are pattern 1 "\[RK\]\[RK\]x\[TS\]\[FAST\]"pattern 2 "\[RK\]\[RK\]x\[TS\]\[ILVM\]"pattern 3 "x\[RK\]\[RK\]\[TS\]\[FAST\]"pattern 4 "x\[RK\]\[RK\]\[TS\]\[ILVM\]"pattern 5 "\[RK\]\[RK\]\[RK\]\[TS\]\[ILVM\]"pattern 6 "\[RK\]\[RK\]\[RK\]\[TS\]\[FAST\]"

Additional filters can be applied to the number of pattern matches in a set protein region, data based on the percentage of amino acids predicted to be in disorder in the region, the maximum identity between two pattern containing regions in orthologous proteins, and annotations to select Gene Ontology terms or mitosis pathways.

The code is available at the links below:

[https://github.com/AlastairKerr/DereticWelburnPreprocessing Scripts](https://github.com/AlastairKerr/DereticWelburnPreprocessingScripts)

All code that was used for preprocessing the data as well as the r-shiny application is available on github.

Preprocessing: [https://github.com/AlastairKerr/DereticWelburn PreprocessingScripts](https://github.com/AlastairKerr/DereticWelburnPreprocessingScripts)

R-Shiny application: [https://github.com/AlastairKerr/Deretic WelburnApp](https://github.com/AlastairKerr/DereticWelburnApp)

The phosphorylation search database is also found at <http://bifx-rta.bio.ed.ac.uk:3838/Welburn/Patterns_Regions/>

Supplementary Material
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MCAK

:   mitotic centromere-associated kinesin

SPICE1

:   [spi]{.ul}ndle and [ce]{.ul}ntriole associated protein 1
